When was Panacea founded?

Panacea was founded in 1999 and raised its 1st funding round 14 years after it was founded.

Where is Panacea located?

Panacea is headquartered in Kolar, India. It is registered at Plot No.35 4th Phase, KIADB Industrial Area, Kolar, Malur, Karnataka, India, 563130.

Who is the current CEO of Panacea?

Raghu Padmanabhan of Panacea. They have also founded 1 company.

How many employees does Panacea have?

As of Aug 31, 2025, the latest employee count at Panacea is 361.

Is Panacea a funded company?

Panacea is a funded company, having raised a total of $15.4M across 5 funding rounds to date. The company's 1st funding round was a $***** Unattributed round, raised on Dec 27, 2013.

How much is Panacea worth?

The latest valuation of Panacea is ₹***** as of Mar 05, 2025.

When was the latest funding round of Panacea?

Panacea's latest funding was a $***** Series B round on Jan 02, 2025, with participation from 1 investor.

What is the annual revenue of Panacea?

Annual revenue of Panacea is ₹99.6Cr as on Mar 31, 2025.

Where does Panacea rank among its competitors?

Panacea ranks 2nd amongst 15 active competitors, of which 5 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Panacea, which secured $5.8M in Jan, 2025.

Who are the top competitors of Panacea?

Panacea's top competitors include BetaGlue Technologies, Viewraysystems and EMulate Therapeutics. Among them, Panacea secured the most recent funding round in January, 2025.

Panacea - 2026 Company Profile, Team, Funding & Competitors

Panacea is a series B company based in Kolar (India), founded in 1999 by G V Subrahmanyam and Raghu Padmanabhan. It operates as a Developer of devices for radiotherapy. Panacea has raised $15.4M in funding from investors like New Enterprise Associates, Tara Fund and Claypond Capital, with a current valuation of ₹*****. The company has 15 active competitors, including 5 funded and 4 that have exited. Its top competitors include companies like BetaGlue Technologies, Viewraysystems and EMulate Therapeutics.

Company Details

Developer of devices for radiotherapy. The product Bhabhatron MLC and Bhabhatron 3 are gamma therapy units, Imagin is an advanced radiotherapy simulator, Siddharth II has stereotactic Imaging, and Impact for immobilization and patient positioning. The company also has mammography units which include Lilac 2DC, Lilac 2DD, and Lilac.

Website: www.panaceamedical.in/
Social
Email ID: *****@panaceamedical.com
Phone Number: +91 **********
Registered Address: Plot No.35 4th Phase, KIADB Industrial Area, Kolar, Malur, Karnataka, India, 563130

Key Metrics

Founded Year

1999

Location

Kolar, India

Stage

Series B

Total Funding

$15.4M in 5 rounds

Latest Funding Round

Series B, Jan 02, 2025, $*****

Post Money Valuation

₹***** as on Mar 05, 2025

Investors

New Enterprise Associates & 13 more

Ranked

2^nd among 15 active competitors

Annual Revenue

₹99.6Cr as on Mar 31, 2025

Employee Count

361 as on Aug 31, 2025

Similar Companies

BetaGlue Technologies & 17 more

View Panacea's full profile

Panacea is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
PANACEA MEDICAL TECHNOLOGIES PRIVATE LIMITED CIN: U33112KA1999PTC079963 , India, Active	Mar 26, 1999	$11.8M (As on Mar 31, 2025)	413 (As on Aug 01, 2025)

Panacea has raised a total funding of $15.4M over 5 rounds. Its first funding round was on Dec 27, 2013. Its latest funding round was a Series B round on Jan 02, 2025 for $*****. 1 investor participated in its latest round. Panacea has 4 institutional investors and 10 angel investors.

Here is the list of recent funding rounds of Panacea:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 02, 2025	5351275	Series B	6774876	2763649	2603565	2186972
Aug 22, 2019	2599806	Series B	7109994	4241658	8970201	7189868
Jan 24, 2017	2320853	Series B	8657194	3701082	Tara Fund	New Enterprise Associates

Access funding benchmarks and valuations. Sign up today!

View details of Panacea's funding rounds and investors

The founders of Panacea are G V Subrahmanyam and Raghu Padmanabhan. Raghu Padmanabhan is the CEO of Panacea.

Here are the details of Panacea's key team members:

G V Subrahmanyam: Co-Founder & Managing Director of Panacea and founder of 1 other company.
Contact Info: 2 email addresses
Raghu Padmanabhan: Co-Founder & CEO of Panacea.

Panacea's Board of Directors

Panacea's board has 6 active members. Tarun Sharma, Charles Antoine Janssen, Bala C Deshpande, Satyalakshmi Goteti, Ramann Yerramilli and Nagavalli Goteti are independent board members.

Here is the list of Panacea's board of directors:

Name	Type	Representing	Status	Duration
Tarun Sharma	Independent board member	-	Current	10y 5m
utabftv	Independent board member	-	Current	1y 7m
ubijweb	Independent board member	-	Current	1y 2m
rmkslaq	Independent board member	-	Current	3y 5m
vtcxomm	Independent board member	-	Current	6y 8m
jajqkk{	Independent board member	-	Current	8y 6m

View details of Panacea's Founder profiles and Board Members

Panacea's employee count trend

Panacea has 361 employees as of Aug 25. The total employee count is 6.0% more than what it was in Aug 24. Here is Panacea's employee count trend over the years:

Uncover Panacea's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Panacea include BetaGlue Technologies, Viewraysystems and EMulate Therapeutics. Here is the list of Top 10 competitors of Panacea, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	BetaGlue Technologies 2017, Milano (Italy), Series A	Provider of a radiotherapy platform for the treatment of solid tumors	$18.9M	Neva SGR, LIFTT & 7 others	52/100
2nd	Panacea 1999, Kolar (India), Series B	Developer of devices for radiotherapy	$15.4M	New Enterprise Associates, Claypond Capital ... & 12 others	48/100
3rd	Viewraysystems 2004, Lage (Germany), Public	Manufacturer of MRI-guided radiation therapy systems for cancer treatment	$177M	F-Prime Capital, Next47 & 12 others	46/100
4th	EMulate Therapeutics 2002, Seattle (United States), Public	Developer of radiofrequency based devices for treatment of cancers	$23.2M	-	40/100
5th	Kallisio 2022, Baltimore (United States), Unfunded	Developer of 3D printed oral stents for head and neck cancer patients	-	-	40/100
6th	RITA Medical Systems 1994, Fremont (United States), Acquired	Products for oncology therapy	-	Avista Capital Partners, Synergy Ventures	33/100
7th	Innoblative Designs 2013, Chicago (United States), Seed	Developer of electrosurgical devices for multiple surgical procedures	$3.26M	Village Capital, VentureWell	32/100
8th	Medsphere 2002, Shanghai (China), Series A	Developer of radiofrequency ablation and minimally invasive electrosurgical medical devices	-	TF Capital, JAFCO Asia & 1 others	31/100
9th	Ehmet Health 2015, Plymouth (United States), Seed	Developer of radiotherapeutic devices for treating breast cancer	$150K	-	28/100
10th	Zidan Medical 2018, Cupertino (United States), Funding Raised	Developer of ablation device for treatment of lung cancer patients	-	Quan Capital, Quan Capital	27/100